From the complexities of the Jalen Hurts case to the confounding risks of marijuana use, our experts continue to provide clarity in a media landscape dominated by nonsense. Here's a look at recent media pickups and features highlighting ACSH coverage.
Popular Mechanics turned to ACSH’s own vascular surgeon, Dr. Chuck Dinerstein, to cut through the noise surrounding the NFL’s recent medical review of quarterback Jalen Hurts. Dinerstein emphasizes that working backward from a poor clinical outcome to assume a mistake is bad medicine. He highlights the necessity of medical nuance when interpreting complex clinical decisions that were made using the information available at the time, rather than in hindsight.
In Reason, ACSH’s Director of Chemical and Pharmaceutical Sciences, Josh Bloom, joined Dr. Jeffrey Singer to explore why Quaaludes—a drug essentially extinct for decades—are seeing a niche comeback. They argue that the "Iron Law of Prohibition" remains in full effect: by forcing users into the black market, government restrictions ensure that the final product is often less pure and more dangerous than a regulated pharmaceutical prescribed by a physician.
We are pleased to report that ACSH contributor Dr. Barbara Pfeffer Billauer has joined the advisory council of the Atlantic Legal Foundation. As an internationally recognized scholar in public health law and bioethics, Billauer’s work consistently demonstrates the importance of rigorous science in the courtroom.
Finally, RealClearScience recently featured ACSH’s analysis of a study linking marijuana legalization to cardiovascular issues. We pointed out a critical failure in the research: the authors studied "legalization" trends rather than actual marijuana consumption. Without data on whether the hospitalized patients even used the drug, the findings regarding heart disease remain speculative at best.
Category
